Explore our media store

Choose your required content type and access a wide range of materials relating to our company, people, medicines and diagnostic tools.

Media Releases

All

Published on: 17 April 2018

FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors

Roche today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Hemlibra® (emicizumab-kxwh) for people with haemophilia A without factor VIII ...

Published on: 16 April 2018

Roche to present new data at AAN highlighting extensive research for OCREVUS and expanding neuroscience pipeline

Roche announced today that new data on its approved and investigational medicines for neurological conditions will be presented during the 70th American Academy of Neurology (AAN) Annual Meeting from ...

Published on: 6 April 2018

Roche completes acquisition of Flatiron Health

Roche today announced that it has completed the acquisition of Flatiron Health, a privately held healthcare technology and services company headquartered in New York City, US. Flatiron Health is a ...

For media requests

+41 61 688 8888

Media Relations Team

For all general enquiries

Please call the Roche switchboard on
Phone:+41 61 688 11 11

Pipeline

Get up-to-date information about our Pharma and Diagnostics pipeline.

From idea to medicine - drug development at Roche.

@Roche on Twitter

Roche stories

All

Published on: 13 October 2016